Company
Description
Founded in 2023, Illumos pioneers deep labelling reagents for light-sheet microscopy in research. Our goal is to revolutionise clinical diagnostics, making a significant impact on next-generation health care.
At Illumos Limited, where doctors, strategists, scientists, and researchers collaborate to transform healthcare delivery with groundbreaking solutions for medical research and improved patient care.
Technology
Pioneering 3D tissue imaging to advance diagnostics and understand diseases.
